Back to Search
Start Over
[Primary-refractory forms of Hodgkin's lymphoma].
- Source :
-
Voprosy onkologii [Vopr Onkol] 2012; Vol. 58 (5), pp. 627-38. - Publication Year :
- 2012
-
Abstract
- Retrospective analysis defined risk factors of primary-refractory course of Hodgkin's lymphoma as well as adverse prognostic factors, efficacy of I and II therapy lines in patients with primary-refractory forms of Hodgkin's lymphoma. By means of discriminant analysis risk factors were as follows: massive tumor lesion, chemotherapy as compared to chemoradiotherapy in the I line, intoxication symptoms, IPS > or = 3, LDH level more than 1,5xULN, late beginning of specialized treatment (over 12 months from initial symptoms of disease), damage of 5 and more areas of lymph nodes, age more than 45 years, increase of ESR higher than 30 mm/h in Stage B and 50 MM/H in Stage A, Stage IV of disease, leukocyte rate higher than 15 x 10(9)/l, presence of more than one extranodal lesion. As a result there were revealed 4 prognostic factors unfavorably influencing on survival rates in primary-refractory forms of Hodgkin's lymphoma with originally Stages II/IV with poor prognosis. The worst 5-year survival rates were found in the presence of 3 and 4 adverse prognostic factors. These circumstances should be taken into consideration choosing optimal treatment and predicting of success of the proposed treatment.
- Subjects :
- Adult
Aged
Analysis of Variance
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Chemotherapy, Adjuvant
Female
Hodgkin Disease mortality
Humans
Male
Middle Aged
Neoplasm Staging
Prognosis
Radiotherapy, Adjuvant
Retrospective Studies
Risk Assessment
Risk Factors
Survival Analysis
Hodgkin Disease pathology
Hodgkin Disease therapy
Subjects
Details
- Language :
- Russian
- ISSN :
- 0507-3758
- Volume :
- 58
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Voprosy onkologii
- Publication Type :
- Academic Journal
- Accession number :
- 23600279